A structured annual diabetes review for all patients with type 2 diabetes continues to be a quality standard of care as outlined by the Ministry of Health. The annual diabetes review should include assessment and optimisation of management if above target(s) (NB: Should consider revising targets if change in clinical circumstances). Goals and targets of management should be documented
To be effective, any abnormal findings or results above target on the annual diabetes review need to be acted on as outlined below.
NB: Components of the 'annual diabetes review' may be performed at different times throughout the year, but all components should be performed at least once per year
The 'annual diabetes review' should include as a minimum:
Ongoing review of HbA1c and optimisation of glycaemic control if above target. Consider revising targets if change in clinical circumstances
NB: HbA1c should be performed 3 monthly if above target with ongoing changes in treatment regimen and 6 monthly if reached target
Weight and waist circumference and consider treatment for obesity if required